Risk factors for cardiovascular disease after renal transplantation
- PMID: 8232106
Risk factors for cardiovascular disease after renal transplantation
Abstract
The incidence of cardiovascular disease is high after renal transplantation. Risk factors include pretransplant cardiovascular disease, diabetes, male sex, serum cholesterol, hypertension, cigarette smoking, and allograft dysfunction. Prevention of cardiovascular disease can probably best be approached by modifying multiple risk factors. Thus, efforts should be made to identify and treat patients with severe coronary artery disease before transplantation. After transplantation, hypertension and hyperlipidemia should be treated, and efforts should be made to help patients abstain from smoking. Chronic immunosuppression protocols should attempt to balance the need to prevent allograft rejection with the known adverse effects of immunosuppressive agents on cardiovascular disease. Altogether, an aggressive, coordinated program to modify multiple risk factors is probably the best approach to the prevention of cardiovascular disease after renal transplantation.
Similar articles
-
[Cardiovascular disease after renal transplantation].G Ital Nefrol. 2004 Jan-Feb;21 Suppl 26:S53-66. G Ital Nefrol. 2004. PMID: 15732047 Review. Italian.
-
[Cardiovascular risk and renal transplantation].G Ital Nefrol. 2004 Mar-Apr;21(2):144-55. G Ital Nefrol. 2004. PMID: 15351949 Review. Italian.
-
Cardiovascular disease after renal transplantation.Semin Nephrol. 2000 Mar;20(2):176-87. Semin Nephrol. 2000. PMID: 10746859 Review.
-
Cardiac allograft vasculopathy after heart transplantation: risk factors and management.J Heart Lung Transplant. 2004 May;23(5 Suppl):S187-93. doi: 10.1016/j.healun.2004.03.009. J Heart Lung Transplant. 2004. PMID: 15093804 Review.
-
Dyslipidemia and its management after renal transplantation.J Nephrol. 2001 Nov-Dec;14 Suppl 4:S81-8. J Nephrol. 2001. PMID: 11798152 Review.
Cited by
-
Pancreas transplantation.Int J Pancreatol. 1995 Feb;17(1):1-13. doi: 10.1007/BF02788353. Int J Pancreatol. 1995. PMID: 8568329 Review. No abstract available.
-
A practical guide to the management of hypertension in renal transplant recipients.Drugs. 1999 Dec;58(6):1011-27. doi: 10.2165/00003495-199958060-00005. Drugs. 1999. PMID: 10651388 Review.
-
Fluvastatin (Lescol) treatment of hyperlipidaemia in patients with renal transplants.Int Urol Nephrol. 1997;29(1):95-106. doi: 10.1007/BF02551424. Int Urol Nephrol. 1997. PMID: 9203045
-
Calcineurin inhibitors and post-transplant hyperlipidaemias.Drug Saf. 2001;24(10):755-66. doi: 10.2165/00002018-200124100-00004. Drug Saf. 2001. PMID: 11676303 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical